Management of infections involving implanted cardiac electrophysiologic devices

Current Treatment Options in Cardiovascular Medicine

Volumn 10, Issue 5, 2008, Pages 380-387

  Paulin, Frédéric L ^a   Gula, Lorne J ^a   Yee, Raymond ^a   Skanes, Allan C ^a   Klein, George J ^a   Krahn, Andrew D ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CEFALEXIN; CEFAZOLIN; CLINDAMYCIN; CLOXACILLIN; CORTICOSTEROID; ISOPRENALINE; LEAD; VANCOMYCIN;

ALLERGY; ANTIBIOTIC PROPHYLAXIS; ARTIFICIAL HEART PACEMAKER; ASEPSIS; BACTERIUM CONTAMINATION; BLOOD CULTURE; CLINICAL FEATURE; DEBRIDEMENT; DEFIBRILLATOR; DEVICE INFECTION; DRUG SAFETY; ECHOCARDIOGRAPHY; ENDOCARDITIS; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; IMMUNE RESPONSE; INCIDENCE; INFECTION CONTROL; LEUKOCYTE COUNT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MONOTHERAPY; NONHUMAN; OSTEOMYELITIS; PATHOPHYSIOLOGY; PERIOPERATIVE PERIOD; POPULATION BASED CASE CONTROL STUDY; REIMPLANTATION; REVIEW; RISK FACTOR; SEPSIS; SINGLE DRUG DOSE; STAPHYLOCOCCUS AUREUS; TRANSTHORACIC ECHOCARDIOGRAPHY; VEIN THROMBOSIS;

EID: 58649110174     PISSN: 10928464     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11936-008-0029-6     Document Type: Review

References (32)

1. Voigt A, Shalaby A, Saba S: Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J Am Coll Cardiol 2006, 48: 590-591.
2. Baddour LM, Bettmann MA, Bolger AF, et al.: Nonvalvular cardiovascular device-related infections. Circulation 2003, 108: 2015-2031.
3. Duval X, Selton-Suty C, Alla F, et al.: Endocarditis in patients with a permanent pacemaker: A 1-year epidemiological survey on infective endocarditis due to valvular and/or pacemaker infection. Clin Infect Dis 2004, 39: 68-74.
4. Uslan DZ, Sohail MR, St Sauver JL, et al.: Permanent pacemaker and implantable cardioverter defibrillator infection: A population-based study. Arch Intern Med 2007, 167: 669-675.
5. Klug D, Balde M, Pavin D, et al.: Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: Results of a large prospective study. Circulation 2007, 116: 1349-1355.
6. Da Costa A, Leliévre H, Kirkorian G, et al.: Role of the preaxillary flora in pacemaker infections: A prospective study. Circulation 1998, 97: 1791-1795.
7. Chamis AL, Peterson GE, Cabell CH, et al.: Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators. Circulation 2001, 104: 1029-1033.
8. Uslan DZ, Sohail MR, Friedman PA, et al.: Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with gram-negative bacteremia. Clin Infect Dis 2006, 43: 731-736.
9. Bloom H, Heeke B, Leon A, et al.: Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing Clin Electrophysiol 2006, 29: 142-145.
10. Sohail MR, Uslan DZ, Khan AH, et al.: Risk factor analysis of permanent pacemaker infection. Clin Infect Dis 2007, 45: 166-173.
11. Da Costa A, Kirkorian G, Cucherat M, et al.: Antibiotic prophylaxis for permanent pacemaker implantation: A meta-analysis. Circulation 1998, 97: 1796-1801.
12. Bertaglia E, Zerbo F, Zardo S, et al.: Antibiotic prophylaxis with a single dose of cefazolin during pacemaker implantation: Incidence of long-term infective complications. Pacing Clin Electrophysiol 2006, 29: 29-33.
13. Chua JD, Wilkoff BL, Lee I, et al.: Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med 2000, 133: 604-608.
14. Sohail MR, Uslan DZ, Khan AH, et al.: Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol 2007, 49: 1851-1859.
15. Klug D, Lacroix D, Savoye C, et al.: Systemic infection related to endocarditis on pacemaker leads: Clinical presentation and management. Circulation 1997, 95: 2098-2107.
16. Voet JG, Vandekerckhove YR, Muyldermans LL, et al.: Pacemaker lead infection: Report of three cases and review of the literature. Heart 1999, 81: 88-91.
17. Klug D, Wallet F, Lacroix D, et al.: Local symptoms at the site of pacemaker implantation indicate latent systemic infection. Heart 2004, 90: 882-886.
18. Dy Chua J, Abdul-Karim A, Mawhorter S, et al.: The role of swab and tissue culture in the diagnosis of implantable cardiac device infection. Pacing Clin Electrophysiol 2005, 28: 1276-1281.
19. Howarth DM, Curteis PG, Gibson S: Infected cardiac pacemaker wires demonstrated by Tc-99m labeled white blood cell scintigraphy. Clin Nucl Med 1998, 23: 74-76.
20. Wickline SA, Fischer KC: Can infections be imaged in implanted devices? ASAIO J 2000, 46: S80-S81.
21. Rosenbaum GS, Calubiran O, Cunha BA: Haemophilus parainfluenzae bacteremia associated with a pacemaker wire localized by gallium scan. Heart Lung 1990, 19: 271-273.
22. Victor F, De Place C, Camus C, et al.: Pacemaker lead infection: echocardiographic features, management, and outcome. Heart 1999, 81: 82-87.
23. Lewis AB, Hayes DL, Holmes DR Jr, et al.: Update on infections involving permanent pacemakers. Characterization and management. J Thorac Cardiovasc Surg 1985, 89: 758-763.
24. Wilkoff BL, Byrd CL, Love CJ, et al.: Pacemaker lead extraction with the laser sheath: Results of the pacing lead extraction with the excimer sheath (PLEXES) trial. J Am Coll Cardiol 1999, 33: 1671-1676.
25. Nguyen K-T, Neese P, Kessler DJ: Successful laser-assisted percutaneous extraction of four pacemaker leads associated with large vegetations. Pacing Clin Electrophysiol 2000, 23: 1260-1262.
26. Ruttmann E, Hangler HB, Kilo J, et al.: Transvenous pacemaker lead removal is safe and effective even in large vegetations: An analysis of 53 cases of pacemaker lead endocarditis. Pacing Clin Electrophysiol 2006, 29: 231-236.
27. Ghosh N, Yee R, KIein GJ, et al.: Laser lead extraction: is there a learning curve? Pacing Clin Electrophysiol 2005, 28: 180-184.
28. Baddour LM, Infectious Diseases Society of America's Emerging Infections Network: Long-term suppressive antimicrobial therapy for intravascular device-related infections. Am J Med Sci 2001, 322: 209-212.
29. Darouiche RO: Treatment of infections associated with surgical implants. N Engl J Med 2004, 350: 1422-1429.
30. Chihrin SM, Mohamed U, Yee R, et al.: Utility of isoproterenol in unmasking latent escape rhythm in pacemaker dependent patients undergoing pacemaker replacement. Am J Cardiol 2008, 101: 631-633.
31. Chihrin SM, Mohammed U, Yee R, et al.: Utility and cost effectiveness of temporary pacing using active fixation leads and an externally placed reusable permanent pacemaker. Am J Cardiol 2006, 98: 1613-1615.
32. Nandyala R, Parsonnet V: One stage side-to-side replacement of infected pulse generators and leads. Pacing Clin Electrophysiol 2006, 29: 393-396.